Aldeyra

ALDX NASDAQ
5.27
-0.14
-2.59%
Closed 17:04 07/19 EDT
Open
5.40
Prev Close
5.41
High
5.50
Low
5.24
Volume
332.28K
Avg Vol (3M)
255.27K
52 Week High
16.70
52 Week Low
4.990
% Turnover
1.21%
Market Cap
144.88M
1D
5D
1M
3M
1Y
5Y

Related

Webull offers Aldeyra ALDX stock price, real time market quotes, professional analyst ratings, and in-depth charts, You can share investing ideas in community to communicate with others and learn trading skills.

Company Profile

Aldeyra Therapeutics, Inc., formerly Aldexa Therapeutics, Inc., is a biotechnology company. The Company's principal activities include raising capital and research and development activities. The Company's segment is the identification and development of a treatment for diseases related to high levels of aldehydes. The Company is focused on the development of products for diseases caused by inflammation and inborn errors of metabolism that are caused by naturally occurring toxic and pro-inflammatory chemical species known as aldehydes. The Company has developed a series of aldehyde traps, molecules that are designed to sequester and allow for the degradation of aldehydes. The Company's aldehyde trap, NS2, is a product candidate that is under development for the treatment of allergic conjunctivitis and related rare allergic ocular diseases, noninfectious anterior uveitis, sjogren-larsson syndrome (SLS) and succinic semi-aldehyde dehydrogenase deficiency.
MORE >

Recently

Name
Price
%Change